Grant Starey
Family · Lakeway, TXNPI 1477003358
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 79.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $1,417 and has fallen 86.5% since, to $192 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Relievant Medsystems, Inc.$162
- Arbor Pharmaceuticals, Inc.$75
- Collegium Pharmaceutical, Inc.$70
- Kowa Pharmaceuticals America, Inc.$60
- GRT US Holding, Inc.$51
- plus $319 from 14 others
What the payments were for
- Food & beverage$3,646100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 173 | $2,909 |
| Relievant Medsystems, Inc. | 3 | $162 |
| Arbor Pharmaceuticals, Inc. | 5 | $75 |
| Collegium Pharmaceutical, Inc. | 4 | $70 |
| Kowa Pharmaceuticals America, Inc. | 3 | $60 |
| GRT US Holding, Inc. | 2 | $51 |
| Johnson & Johnson | 1 | $45 |
| Boston Scientific | 1 | $41 |
| Si-bone, Inc. | 1 | $30 |
| Pfizer | 2 | $30 |
| Boehringer Ingelheim | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $24 |
| Medtronic | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Sonex Health, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$426
How this compares
$3,646 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $179 |
Paid to pharmacies, not to this prescriber.
Other family in Lakeway
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.